Enlightify amends 8-K to clarify Tianping Cai's board appointment, independent director terms

Enlightify Inc.

Appointment effective April 10, 2025, as board member, audit committee chair, and member of nominating/comp committees.
Cai serves as Financial Director at HK Haoming International (medical device); prior risk management/audit at real estate firms.
Independent Director Agreement signed June 5, 2025, provides $26,000 annual fee; supersedes prior Employment Agreement.
Board determined Cai qualifies as audit committee financial expert and is independent under NYSE/SEC rules.
Cai holds no beneficial ownership of ENFY stock and has no material interest in any transactions.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Tianping Cai

Director

ENFY · Enlightify Inc.

Effective: 2025-04-10
Filed: June 5, 2025, 7:59 PM ET

appointed Mr. Tianping Cai to serve on the Board of Directors of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tianping Cai was appointed as Director at Enlightify Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Mr. Tianping Cai to serve on the Board of Directors of the Company.

View on SEC.gov

Enlightify Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-051625

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.